
Christopher Y. Kim
Examiner (ID: 18274)
| Most Active Art Unit | 1801 |
| Art Unit(s) | 1744, 2876, 1801, 1312 |
| Total Applications | 419 |
| Issued Applications | 342 |
| Pending Applications | 16 |
| Abandoned Applications | 61 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17838095
[patent_doc_number] => 20220275400
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => METHODS FOR SCALABLE GENE INSERTIONS
[patent_app_type] => utility
[patent_app_number] => 17/637710
[patent_app_country] => US
[patent_app_date] => 2020-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26640
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17637710
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/637710 | METHODS FOR SCALABLE GENE INSERTIONS | Aug 30, 2020 | Abandoned |
Array
(
[id] => 17838095
[patent_doc_number] => 20220275400
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => METHODS FOR SCALABLE GENE INSERTIONS
[patent_app_type] => utility
[patent_app_number] => 17/637710
[patent_app_country] => US
[patent_app_date] => 2020-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26640
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17637710
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/637710 | METHODS FOR SCALABLE GENE INSERTIONS | Aug 30, 2020 | Abandoned |
Array
(
[id] => 20173214
[patent_doc_number] => 12391948
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-19
[patent_title] => RNA-regulated fusion proteins and methods of their use
[patent_app_type] => utility
[patent_app_number] => 17/637940
[patent_app_country] => US
[patent_app_date] => 2020-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 49
[patent_figures_cnt] => 68
[patent_no_of_words] => 20984
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 104
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17637940
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/637940 | RNA-regulated fusion proteins and methods of their use | Aug 30, 2020 | Issued |
Array
(
[id] => 16824633
[patent_doc_number] => 20210139926
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-13
[patent_title] => PLANT GENOME EDITING
[patent_app_type] => utility
[patent_app_number] => 17/005090
[patent_app_country] => US
[patent_app_date] => 2020-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15622
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17005090
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/005090 | PLANT GENOME EDITING | Aug 26, 2020 | Abandoned |
Array
(
[id] => 16513287
[patent_doc_number] => 20200392545
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-17
[patent_title] => PRODUCTION OF FRAMBINONE BY A RECOMBINANT FUNGAL MICROORGANISM
[patent_app_type] => utility
[patent_app_number] => 17/004863
[patent_app_country] => US
[patent_app_date] => 2020-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12694
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17004863
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/004863 | Production of frambinone by a recombinant fungal microorganism | Aug 26, 2020 | Issued |
Array
(
[id] => 17850403
[patent_doc_number] => 20220280444
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-08
[patent_title] => Compositions Comprising Decarboxylated Cannabinoids
[patent_app_type] => utility
[patent_app_number] => 17/638379
[patent_app_country] => US
[patent_app_date] => 2020-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4050
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -35
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17638379
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/638379 | Compositions Comprising Decarboxylated Cannabinoids | Aug 25, 2020 | Pending |
Array
(
[id] => 17228900
[patent_doc_number] => 20210355456
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-18
[patent_title] => RECOMBINANT VECTOR AND METHOD FOR PRODUCING RECONSTITUTED CYTOCHROME P450 OXYGENASE-REDUCTASE FUSION PROTEIN USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 16/995168
[patent_app_country] => US
[patent_app_date] => 2020-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8268
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16995168
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/995168 | Recombinant vector and method for producing reconstituted cytochrome P450 oxygenase-reductase fusion protein using the same | Aug 16, 2020 | Issued |
Array
(
[id] => 16506435
[patent_doc_number] => 20200385691
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-10
[patent_title] => METHOD FOR PURIFICATING AND CRYSTALLIZATING LPOR PROTEIN AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/993847
[patent_app_country] => US
[patent_app_date] => 2020-08-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9611
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16993847
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/993847 | Method for purificating and crystallizating LPOR protein and use thereof | Aug 13, 2020 | Issued |
Array
(
[id] => 16992154
[patent_doc_number] => 20210230574
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => ORGANIC-INORGANIC HYBRID NANOFLOWER AND PREPARATION METHOD THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/991660
[patent_app_country] => US
[patent_app_date] => 2020-08-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4705
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16991660
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/991660 | Organic-inorganic hybrid nanoflower and preparation method thereof | Aug 11, 2020 | Issued |
Array
(
[id] => 17837718
[patent_doc_number] => 20220275023
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => PRODUCTION OF PROTEIN SOLID MATERIAL
[patent_app_type] => utility
[patent_app_number] => 17/632739
[patent_app_country] => US
[patent_app_date] => 2020-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13159
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17632739
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/632739 | PRODUCTION OF PROTEIN SOLID MATERIAL | Aug 5, 2020 | Pending |
Array
(
[id] => 17287223
[patent_doc_number] => 11203764
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-12-21
[patent_title] => Kaurenoic acid hydroxylases
[patent_app_type] => utility
[patent_app_number] => 16/938483
[patent_app_country] => US
[patent_app_date] => 2020-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 17661
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16938483
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/938483 | Kaurenoic acid hydroxylases | Jul 23, 2020 | Issued |
Array
(
[id] => 16399111
[patent_doc_number] => 20200339969
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-29
[patent_title] => ALPHA-AMYLASE VARIANTS
[patent_app_type] => utility
[patent_app_number] => 16/928207
[patent_app_country] => US
[patent_app_date] => 2020-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21814
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16928207
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/928207 | Alpha-amylase variants | Jul 13, 2020 | Issued |
Array
(
[id] => 17981079
[patent_doc_number] => 20220347115
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-03
[patent_title] => NANOPARTICLE SYSTEMS FOR TARGETED DELIVERY OF CRISPR/CAS13 AND METHODS OF USING SAME
[patent_app_type] => utility
[patent_app_number] => 17/626482
[patent_app_country] => US
[patent_app_date] => 2020-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13526
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17626482
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/626482 | NANOPARTICLE SYSTEMS FOR TARGETED DELIVERY OF CRISPR/CAS13 AND METHODS OF USING SAME | Jul 12, 2020 | Pending |
Array
(
[id] => 17236895
[patent_doc_number] => 11180767
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-23
[patent_title] => Protease deficient filamentous fungal cells and methods of use thereof
[patent_app_type] => utility
[patent_app_number] => 16/912787
[patent_app_country] => US
[patent_app_date] => 2020-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 46
[patent_figures_cnt] => 91
[patent_no_of_words] => 65339
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16912787
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/912787 | Protease deficient filamentous fungal cells and methods of use thereof | Jun 25, 2020 | Issued |
Array
(
[id] => 16571034
[patent_doc_number] => 20210010040
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-14
[patent_title] => D-Lactate Dehydrogenase, Engineered Strain Containing D-Lactate Dehydrogenase and Construction Method and Use of Engineered Strain
[patent_app_type] => utility
[patent_app_number] => 16/910127
[patent_app_country] => US
[patent_app_date] => 2020-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13122
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16910127
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/910127 | D-lactate dehydrogenase, engineered strain containing D-lactate dehydrogenase and construction method and use of engineered strain | Jun 23, 2020 | Issued |
Array
(
[id] => 16570965
[patent_doc_number] => 20210009971
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-14
[patent_title] => MODIFIED HELICASES
[patent_app_type] => utility
[patent_app_number] => 16/893332
[patent_app_country] => US
[patent_app_date] => 2020-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44239
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16893332
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/893332 | Modified helicases | Jun 3, 2020 | Issued |
Array
(
[id] => 18964424
[patent_doc_number] => 11898176
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-13
[patent_title] => Genetic correction of mutated genes
[patent_app_type] => utility
[patent_app_number] => 16/890232
[patent_app_country] => US
[patent_app_date] => 2020-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 13
[patent_no_of_words] => 15892
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 145
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16890232
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/890232 | Genetic correction of mutated genes | Jun 1, 2020 | Issued |
Array
(
[id] => 18964424
[patent_doc_number] => 11898176
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-13
[patent_title] => Genetic correction of mutated genes
[patent_app_type] => utility
[patent_app_number] => 16/890232
[patent_app_country] => US
[patent_app_date] => 2020-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 13
[patent_no_of_words] => 15892
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 145
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16890232
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/890232 | Genetic correction of mutated genes | Jun 1, 2020 | Issued |
Array
(
[id] => 18964424
[patent_doc_number] => 11898176
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-13
[patent_title] => Genetic correction of mutated genes
[patent_app_type] => utility
[patent_app_number] => 16/890232
[patent_app_country] => US
[patent_app_date] => 2020-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 13
[patent_no_of_words] => 15892
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 145
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16890232
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/890232 | Genetic correction of mutated genes | Jun 1, 2020 | Issued |
Array
(
[id] => 16312638
[patent_doc_number] => 20200291376
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-09-17
[patent_title] => MODIFIED MEMBRANE TYPE SERINE PROTEASE 1 (MTSP-1) POLYPEPTIDES AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 16/890936
[patent_app_country] => US
[patent_app_date] => 2020-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 74907
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -44
[patent_words_short_claim] => 160
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16890936
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/890936 | Nucleic acid encoding modified membrane type serine protease 1 (MTSP-1) polypeptides and methods of use | Jun 1, 2020 | Issued |